Literature DB >> 15971177

Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers.

Sílvia Nosàs-Garcia1, Thomas Moehler, Klaus Wasser, Fabian Kiessling, Reiner Bartl, Ivan Zuna, Jens Hillengass, Hartmut Goldschmidt, Hans-Ulrich Kauczor, Stefan Delorme.   

Abstract

PURPOSE: To examine whether parameters of dynamic, contrast-enhanced MRI (DCE MRI) reflect the degree of infiltration and vessel density in corresponding bone marrow biopsy specimens.
MATERIALS AND METHODS: The pelvis of 24 patients with multiple myeloma (MM) was examined using contrast-enhanced DCE MRI. Biopsy was obtained from the spina iliaca posterior superior. Using a two-compartment model (assuming one intravascular and one interstitial compartment), the parameters amplitude (A, the maximum, relative signal increase over baseline) and the exchange rate constant (k(ep), describing the redistribution of contrast agent from the interstitial into the intravascular compartment) in the biopsied region were calculated and compared with the histological and clinical data.
RESULTS: DCE MRI parameters were significantly higher in lesions with marked infiltration than with mild or no infiltration (P < 0.05). The amplitude normalized to that in the iliac artery (A(n)), but not k(ep), was higher in lesions with high vessel-density at histology (P = 0.01). Higher k(ep) levels were found in presence of increased serum immunoglobulins.
CONCLUSION: Increased contrast uptake in the bone marrow of MM patients indicates at least moderate tumor involvement. Furthermore, the contrast enhancement correlates with vessel-density and serum markers of disease activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15971177     DOI: 10.1002/jmri.20349

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  27 in total

Review 1.  The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

Authors:  Jo Caers; Nadia Withofs; Jens Hillengass; Paolo Simoni; Elena Zamagni; Roland Hustinx; Yves Beguin
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

2.  [Multiple myeloma: current recommendations for imaging].

Authors:  J Hillengass; S Delorme
Journal:  Radiologe       Date:  2012-04       Impact factor: 0.635

3.  Dynamic contrast-enhanced optical imaging of in vivo organ function.

Authors:  Cyrus B Amoozegar; Tracy Wang; Matthew B Bouchard; Addason F H McCaslin; William S Blaner; Richard M Levenson; Elizabeth M C Hillman
Journal:  J Biomed Opt       Date:  2012-09       Impact factor: 3.170

Review 4.  Imaging of multiple myeloma: Current concepts.

Authors:  Thorsten Derlin; Peter Bannas
Journal:  World J Orthop       Date:  2014-07-18

Review 5.  Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion.

Authors:  Yaron Gordon; Sasan Partovi; Matthias Müller-Eschner; Erick Amarteifio; Tobias Bäuerle; Marc-André Weber; Hans-Ulrich Kauczor; Fabian Rengier
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

Review 6.  PET/CT and MR imaging in myeloma.

Authors:  Michael E Mulligan; Ashraf Z Badros
Journal:  Skeletal Radiol       Date:  2006-08-17       Impact factor: 2.199

7.  Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy.

Authors:  Deep K Hathi; John A Engelbach; Jens Hillengass; Deborah Veis; Samuel Achilefu; Joel R Garbow; Monica Shokeen
Journal:  NMR Biomed       Date:  2019-06-17       Impact factor: 4.044

Review 8.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

Review 9.  Functional and molecular MRI of the bone marrow in multiple myeloma.

Authors:  Vassilis Koutoulidis; Nickolas Papanikolaou; Lia A Moulopoulos
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

Review 10.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.